Nautilus Biotechnology, Inc. (NAUT)

CIK 1808805 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nautilus Biotechnology, Inc..

Recent SEC filings

FiledFormAccession number
Nov 3, 2026SCHEDULE 13D/A0001193125-26-445289
Oct 27, 20268-K0001808805-26-000049
Oct 27, 202610-Q0001808805-26-000052
Sep 18, 2026424B50001808805-26-000047
Sep 18, 2026EFFECT9999999995-26-003012
Sep 11, 20268-K0001808805-26-000041
Sep 11, 2026SCHEDULE 13D/A0001231919-26-001165
Sep 11, 2026S-30001808805-26-000040
Aug 28, 2026SCHEDULE 13D/A0001725721-26-000006
Aug 14, 2026SCHEDULE 13D/A0001193125-26-352644
Jul 28, 20268-K0001808805-26-000030
Jul 28, 202610-Q0001808805-26-000034
Jun 30, 2026SCHEDULE 13D/A0001725721-26-000004
Jun 22, 202640001234663-26-000002
Jun 22, 202640001381752-26-000001
Jun 22, 202640001797672-26-000004
Jun 22, 202640001543792-26-000002
Jun 22, 202640001807359-26-000008
Jun 18, 20268-K0001808805-26-000027
Jun 4, 2026SCHEDULE 13D/A0001725721-26-000002
Jun 4, 202640001231919-26-000599
Apr 28, 2026DEF 14A0001808805-26-000023
Apr 28, 2026ARS0001808805-26-000025
Apr 28, 20268-K0001808805-26-000015
Apr 28, 202610-Q0001808805-26-000022